We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · August 09, 2022

Gender-Specific Stratification of Survival Following ICI Therapy Based on Intratumoral Expression of a B-Cell Gene Signature

European Urology Oncology


Additional Info

European Urology Oncology
Gender-specific Stratification of Survival Following Immune Checkpoint Inhibitor Therapy Based on Intratumoral Expression of a B cell Gene Signature
Eur Urol Oncol 2022 Jun 01;5(3)338-346, AK Aragaki, Y Jing, J Hoffman-Censits, W Choi, NM Hahn, BJ Trock, DJ McConkey, BA Johnson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading